Synthesis of carbocyclic purine nucleosides using key intermediates, carbocyclic AICA-ribosides. 1987

R Marumoto, and Y Taniyama, and T Fukuda
Biotechnology Laboratories, Takeda Chemical Industries Ltd, Osaka, Japan.

Treating carbocyclic N1-methoxymethy-inosine and 2'-deoxy-inosine with 1N-NaOH/aq.EtOH gave the carbocyclic 5-amino-4-imidazolecarboxamide-riboside and -2'-deoxyriboside respectively. Reaction of both useful key intermediates with PhCONCS afforded the corresponding 5-(N-isothiocarbamoyl) derivatives in high yield. Methylation of the isothiocarbamoyl groups, followed by treatment with NaOH led to the purine ring-closure (guanine, isoguanine, and xanthosine) reaction.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008745 Methylation Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed) Methylations
D011684 Purine Nucleosides Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES. Purine Nucleoside,Nucleoside, Purine,Nucleosides, Purine
D000620 Aminoimidazole Carboxamide An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases. Ba 2756,Carboxamide, Aminoimidazole
D012263 Ribonucleosides Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)

Related Publications

R Marumoto, and Y Taniyama, and T Fukuda
July 1995, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
R Marumoto, and Y Taniyama, and T Fukuda
February 1947, The Journal of biological chemistry,
R Marumoto, and Y Taniyama, and T Fukuda
May 1968, Molecular pharmacology,
R Marumoto, and Y Taniyama, and T Fukuda
August 2009, Bioorganic & medicinal chemistry,
R Marumoto, and Y Taniyama, and T Fukuda
April 2000, Organic letters,
R Marumoto, and Y Taniyama, and T Fukuda
March 2022, Current protocols,
R Marumoto, and Y Taniyama, and T Fukuda
January 2003, Nucleosides, nucleotides & nucleic acids,
R Marumoto, and Y Taniyama, and T Fukuda
February 2000, Chemical & pharmaceutical bulletin,
R Marumoto, and Y Taniyama, and T Fukuda
December 1966, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!